LON:AGL - ANGLE Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 107.50
▼ -1.75 (-1.60%)

This chart shows the closing price for AGL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ANGLE Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AGL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AGL

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for ANGLE in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 107.50.

This chart shows the closing price for AGL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in ANGLE. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/10/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/10/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/8/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/6/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/4/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/5/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/4/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/3/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/20/2020FinnCapReiterated RatingCorporate
6/22/2020FinnCapReiterated RatingCorporate
5/12/2020FinnCapReiterated RatingCorporate
4/28/2020FinnCapReiterated RatingCorporate
4/17/2020FinnCapReiterated RatingCorporate
3/31/2020FinnCapReiterated RatingCorporate
2/27/2020FinnCapReiterated RatingCorporate
1/30/2020FinnCapReiterated RatingCorporate
1/22/2020FinnCapReiterated RatingCorporate
10/30/2019FinnCapReiterated RatingCorporate
9/10/2019FinnCapReiterated RatingCorporate
7/31/2019FinnCapReiterated RatingCorporate
6/26/2019FinnCapReiterated RatingCorporate
5/31/2019FinnCapReiterated RatingCorporate
4/26/2019FinnCapReiterated RatingCorporate
4/18/2019FinnCapReiterated RatingCorporate
3/7/2019FinnCapReiterated RatingCorporate
2/25/2019FinnCapReiterated RatingCorporate
1/31/2019FinnCapReiterated RatingCorporate
1/11/2019FinnCapReiterated RatingCorporate
11/5/2018FinnCapReiterated RatingCorporate
10/25/2018FinnCapReiterated RatingCorporate
7/25/2018FinnCapReiterated RatingCorporate
6/26/2018FinnCapBoost Price TargetCorporateGBX 108 ➝ GBX 110
4/19/2018FinnCapReiterated RatingCorporateGBX 108
4/5/2018FinnCapReiterated RatingCorporate
3/26/2018FinnCapReiterated RatingCorporateGBX 108
2/12/2018FinnCapReiterated RatingCorporateGBX 108
1/31/2018FinnCapReiterated RatingCorporateGBX 108
1/8/2018FinnCapReiterated RatingCorporateGBX 108
11/21/2017FinnCapReiterated RatingCorporateGBX 108
10/23/2017FinnCapReiterated RatingCorporateGBX 108
10/9/2017FinnCapReiterated RatingCorporateGBX 108 ➝ GBX 100
9/11/2017FinnCapReiterated RatingCorporateGBX 100
9/5/2017FinnCapInitiated CoverageCorporateGBX 100
7/5/2017Beaufort SecuritiesReiterated RatingSpeculative Buy
6/16/2017Beaufort SecuritiesReiterated RatingSpeculative Buy
6/6/2017Beaufort SecuritiesReiterated RatingSpeculative Buy
5/4/2017Beaufort SecuritiesReiterated RatingSpeculative Buy
3/31/2017Beaufort SecuritiesReiterated RatingSpeculative Buy
2/14/2017Beaufort SecuritiesReiterated RatingSpeculative Buy
1/27/2017Beaufort SecuritiesReiterated RatingSpeculative Buy
11/7/2016Beaufort SecuritiesReiterated RatingSpeculative Buy
(Data available from 8/3/2016 forward)
ANGLE logo
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products worldwide. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in cancer patient blood; and HyCEAD multiplex analysis system used as the downstream analysis tool in the ovarian cancer clinical application. It also offers specialist circulating tumor cell enrichment and analysis services to support translational research studies and pharmaceutical trials. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Read More

Today's Range

Now: GBX 107.50
Low: 106.03
High: 110

50 Day Range

MA: GBX 124.14
Low: 107.50
High: 139

52 Week Range

Now: GBX 107.50
Low: 37.15
High: 143.90

Volume

336,374 shs

Average Volume

972,152 shs

Market Capitalization

£250.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of ANGLE?

The following Wall Street analysts have issued reports on ANGLE in the last year:
View the latest analyst ratings for AGL.

What is the current price target for ANGLE?

0 Wall Street analysts have set twelve-month price targets for ANGLE in the last year. has the lowest price target set, forecasting a price of £100,000 for ANGLE in the next year.
View the latest price targets for AGL.

What is the current consensus analyst rating for ANGLE?

ANGLE currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for AGL.

What other companies compete with ANGLE?

How do I contact ANGLE's investor relations team?

ANGLE's physical mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The company's listed phone number is +44-1483-685830. The official website for ANGLE is www.angleplc.com.